SCHEMBL32669611

SCHEMBL32669611

Cc1ccccc1OCCN(C)C(=O)/C(C#N)=C(\O)c1cc(F)c(O)c(C#N)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HPGD P15428 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
LMNA P02545 2/20 0.36
KDM4E B2RXH2 2/20 0.35
MAPT P10636 2/20 0.35
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
COMT P21964 1/20 0.34
FTO Q9C0B1 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
L3MBTL1 Q9Y468 3/20 0.33
TDP1 Q9NUW8 2/20 0.33
AR P10275 1/20 0.33
DHODH Q02127 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32669968 0.90 ALDH1A1 (0.36) ALDH1A1HPGDCYP2D6KDM4EKMT2A
SCHEMBL32670074 0.89 KMT2A (0.39) ALDH1A1LMNAKMT2ACOMTFTO
SCHEMBL32669882 0.84 HRH1 (0.34) ALDH1A1NPSR1HPGDLMNAKDM4E
SCHEMBL32669504 0.81 SLC22A12 (0.32) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL32669989 0.80 SLC6A9 (0.35) ALDH1A1NPSR1HPGDCYP1A2CYP3A4
SCHEMBL32669865 0.80 RBP4 (0.43) ALDH1A1KDM4EARRBP4
SCHEMBL32669876 0.80 ACHE (0.41) ALDH1A1HPGDKDM4EKMT2AMEN1
SCHEMBL32669776 0.79 GRM2 (0.33) CYP3A4CYP2D6COMTFTO
SCHEMBL32669930 0.79 RAB9A (0.38) ALDH1A1LMNAKDM4EMAPTKMT2A
SCHEMBL32669684 0.78 FTO (0.47) ALDH1A1HPGDCYP2C9MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035341-A1 FTO INHIBITORS FTO, LDLR, GPR119 ALDH1A1 1334/4885NPSR1 300/4885HPGD 3946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.